Ignite Creation Date:
2024-05-06 @ 7:56 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06190509
Status:
RECRUITING
Last Update Posted:
2024-01-05
First Post:
2023-12-19
Brief Title:
Assessing the Safety Immune Response and Early Efficacy of a Candida Vaccine in Women With Recurrent Vulvovaginal Candidiasis A Randomized Controlled Study
Sponsor:
LimmaTech Biologics AG
Organization:
LimmaTech Biologics AG
Organization Data
Organization:
LimmaTech Biologics AG
Class:
INDUSTRY
Study ID:
Candi5V01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
LimmaTech Biologics AG
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| GlaxoSmithKline | INDUSTRY |